LYBALVI
NDC 65757-652, olanzapine and samidorphan L-malate, tablet, film coated, from Alkermes, Inc..
- Product NDC
- 65757-652
- Status
- Listed
- Labeler
- Alkermes, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213378
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65757-652 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLANZAPINE10 mg/1
- SAMIDORPHAN L-MALATE10 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]; Opioid Antagonist [EPC]; Opioid Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65757-652-41 | 65757065241 | 1 BOTTLE in 1 CARTON (65757-652-41) / 7 TABLET, FILM COATED in 1 BOTTLE |
| 65757-652-42 | 65757065242 | 1 BOTTLE in 1 CARTON (65757-652-42) / 30 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/32ffddd1-4e2b-45d9-9b36-bb730167ec80NADAC price for package 65757065242
GET /v1/drugs/nadac/65757065242
Use it
Look up 65757-652 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65757-652 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65757-652. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.